Administrative Core
Administrative Core
批准号:
10707537
负责人:
Pankaj Kumar Singh
金额:
$30.72万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-20 至 2027-08-31
关键词:
Advisory CommitteesAdvocateAreaBasic Cancer ResearchBasic ScienceBioinformaticsBiometryCancer BiologyCancer CenterCollaborationsCommunicationCommunitiesDataData Coordinating CenterDedicationsDevelopmentEducationEnvironmentFacultyFosteringFunding AgencyFutureGoalsGrantHuman ResourcesImmuneInformation DisseminationInfrastructureInstitutionInterventionJointsLaboratoriesLeadLeadershipLinkMalignant NeoplasmsMalignant neoplasm of pancreasMedical centerMetabolicMetabolismMonitorNational Cancer InstituteNebraskaOccupational activity of managing financesOrganoidsPilot ProjectsPostdoctoral FellowProgress ReportsRecordsResearchResearch PersonnelResearch Project GrantsResistanceResourcesScheduleScienceScientistSignal TransductionStromal NeoplasmStudentsTalentsTechnical ExpertiseTestingTissuesTranslational ResearchTravelUniversitiesWorkanticancer researchcancer therapydata integrationgraduate studentinnovationinterestmeetingsmembermouse modelnext generationnovelnovel therapeutic interventionoperationpreventprogramsprospectiveresistance mechanismtherapy resistanttranslational cancer researchtranslational pipelinetranslational research programtumortumor metabolismweb portal
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ADMINISTRATIVE CORE
Abstract
The administrative core will lead, manage, and support all activities of the Acquired Resistance to Therapy
Network (ARTNet) Center for Pancreatic Cancer (ACPC). It will represent ACPC at the trans-ARTNet network
activities, and in interactions with NCI. The ARTNet administrative core will be responsible for managing the
activities of the synergistic research ACPC projects with scientific and technical expertise and resources in the
areas of therapy resistance, signaling, metabolism, pancreatic cancer biology, organoid and mouse models,
immune and non-immune stroma, and PDAC tissues for studying the acquired therapy resistance in cancer. The
core leadership will provide expertise spanning the basic to translational spectrum, consistent with the
overarching theme of ACPC, with track records of building and guiding large scientific teams to successfully
advance fields in transformative ways. We will utilize strategic management with innovative approaches,
including an educational component to bring new talent into the field, engage diverse teams to facilitate new
ideas, leverage national talent pertinent to the proposed goals, engage university leadership in building support
for cutting-edge science, and utilize dedicated university expertise to facilitate engagement with basic and
translational research programs to grow ARTNet centric interests. The administrative core will provide support
for personnel involved in the administration, coordination, communication, biostatistics, and bioinformatics to
support the ARTNet activities within the center and campus, other ARTNet centers, ARTNet Coordinating Data
and Management Center (CDMC) and National Cancer Institutes (NCI). The administrative core will also provide
scientific oversight, result dissemination, budgetary oversight, and clerical functions associated with the overall
research program in this ACPC application. The core will implement center-wide activities which include,
developing new collaborations on the ACPC projects, organize annual retreat, support acquired cancer therapy
resistance seminar speakers within various academic units, advocate for the next generation of scientists
(graduate students, postdoctoral researchers, and junior faculty) in the ACPC member laboratories. Finally, the
administrative core will represent ACPC on the ARTNet steering committee.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metabolic regulation of FOLFIRINOX acquired resistance in pancreatic cancer
-
批准号:10518247
-
项目类别:
-
资助金额:$29.39万
-
财政年份:2022
-
负责人:Pankaj Kumar Singh
-
依托单位:
Pancreatic Cancer ARTNet Center
-
批准号:10707504
-
项目类别:
-
资助金额:$126.6万
-
财政年份:2022
-
负责人:Pankaj Kumar Singh
-
依托单位:
Administrative Core
-
批准号:10518244
-
项目类别:
-
资助金额:$11.83万
-
财政年份:2022
-
负责人:Pankaj Kumar Singh
-
依托单位:
Cancer Metabolism Core
-
批准号:10707540
-
项目类别:
-
资助金额:$9.37万
-
财政年份:2022
-
负责人:Pankaj Kumar Singh
-
依托单位:
Pancreatic Cancer ARTNet Center
-
批准号:10518243
-
项目类别:
-
资助金额:$128.43万
-
财政年份:2022
-
负责人:Pankaj Kumar Singh
-
依托单位:
Cancer Metabolism Core
-
批准号:10518246
-
项目类别:
-
资助金额:$9.64万
-
财政年份:2022
-
负责人:Pankaj Kumar Singh
-
依托单位:
Metabolic regulation of FOLFIRINOX acquired resistance in pancreatic cancer
-
批准号:10707541
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2022
-
负责人:Pankaj Kumar Singh
-
依托单位:
Molecular Basis of ME2-mediated Tumor Suppression in Pancreatic Cancer
-
批准号:10671029
-
项目类别:
-
资助金额:$42.2万
-
财政年份:2022
-
负责人:Pankaj Kumar Singh
-
依托单位:
Mitochondrial calcium signaling in pancreatic cancer metastasis and progression
-
批准号:10363987
-
项目类别:
-
资助金额:$65.54万
-
财政年份:2022
-
负责人:Pankaj Kumar Singh
-
依托单位:
Mitochondrial calcium signaling in pancreatic cancer metastasis and progression
-
批准号:10565949
-
项目类别:
-
资助金额:$62.77万
-
财政年份:2022
-
负责人:Pankaj Kumar Singh
-
依托单位:
Project 3: MUC16-Mediated Metabolic Reprograming Induces PC Metastasis
-
批准号:10203864
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2018
-
负责人:Pankaj Kumar Singh
-
依托单位:
Project 3: MUC16-Mediated Metabolic Reprograming Induces PC Metastasis
-
批准号:10413940
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2018
-
负责人:Pankaj Kumar Singh
-
依托单位:
Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer
-
批准号:10662933
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2017
-
负责人:Pankaj Kumar Singh
-
依托单位:
Targeting the Metabolic Basis of Cachexia in Pancreatic Cancer
-
批准号:10053712
-
项目类别:
-
资助金额:$43.41万
-
财政年份:2016
-
负责人:Pankaj Kumar Singh
-
依托单位:
Targeting the Metabolic Basis of Cachexia in Pancreatic Cancer
-
批准号:10630681
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2016
-
负责人:Pankaj Kumar Singh
-
依托单位:
Targeting MUC1-induced Tumor-stromal Metabolic Cross-talk in Pancreatic Cancer
-
批准号:8370711
-
项目类别:
-
资助金额:$42.86万
-
财政年份:2012
-
负责人:Pankaj Kumar Singh
-
依托单位:
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
-
批准号:10738314
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2012
-
负责人:Pankaj Kumar Singh
-
依托单位:
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
-
批准号:10630607
-
项目类别:
-
资助金额:$44.09万
-
财政年份:2012
-
负责人:Pankaj Kumar Singh
-
依托单位:
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
-
批准号:10679793
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2012
-
负责人:Pankaj Kumar Singh
-
依托单位:
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
-
批准号:10684833
-
项目类别:
-
资助金额:$44.09万
-
财政年份:2012
-
负责人:Pankaj Kumar Singh
-
依托单位:
海外基金